Sarah Gee

4.1k citations
37 papers · 2.8k · 6 hit papers · h-index 17

Impact in

    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 and COVID-19 Research
  • Neurology top 2%
    • Long-Term Effects of COVID-19

Papers in

Sarah Gee

36 papers receiving 2.7k citations

Sarah Gee's Hit Papers

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial 2022 · 282 citations
2820+2+4Years since publication200400600

Peers

Sarah Gee
Comparison fields: 5 of 140
  • Infectious Diseases 1.5k
  • Neurology 582
  • Applied Microbiology and Biotechnology 53
  • Obstetrics and Gynecology 176
  • Internal Medicine 58
Replace Owen R Davies with:
Owen R Davies United Kingdom
Emily London United Kingdom
Tabitha Newman United Kingdom
Susan Hope United Kingdom
Lauren Martinez United Kingdom
Atideb Mitra United Kingdom
Michelle Bruce United Kingdom
Ken Inweregbu United Kingdom
Susie Ferguson United Kingdom
Karen Coy United Kingdom
Sarah Gee relative to Owen R Davies United Kingdom Owen R Davies's profile →
Citations per field
00.5×1.5×2.0×
Owen R Davies · 1×
Citations per year

Countries citing papers authored by Sarah Gee

Since Specialization
Citations

This map shows the geographic impact of Sarah Gee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Gee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Gee more than expected).

Fields of papers citing papers by Sarah Gee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Gee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Gee. The network helps show where Sarah Gee may publish in the future.

Co-authors

The 25 scholars most cited alongside Sarah Gee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sarah Gee Line = papers co-authored together Sarah Gee links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A dynamic COVID-19 immune signature includes associations with poor prognosis
Hit paper breakdown →
2020706
2
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021403
3
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Hit paper breakdown →
2021381
4
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2022282
5
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Hit paper breakdown →
2022230
6
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021211
7 202185
8 202383
9 202181
10 201135
11 201029
12 201024
13 201424
14 202324
15 202423
16 202420
17 200817
18 201017
19 202016
20 200413

About Sarah Gee

Sarah Gee is a scholar working on Infectious Diseases, Tourism, Leisure and Hospitality Management, Epidemiology, Health and Gender Studies, having authored 37 papers that have together received 2.8k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Sport and Mega-Event Impacts (4 papers), Virology and Viral Diseases (4 papers), Syphilis Diagnosis and Treatment (3 papers), Wine Industry and Tourism (3 papers), COVID-19 Clinical Research Studies (2 papers), Substance Abuse Treatment and Outcomes (2 papers) and Reproductive System and Pregnancy (2 papers). The work is most often cited by research in Infectious Diseases (1.5k citations), Neurology (582 citations), Applied Microbiology and Biotechnology (53 citations), Obstetrics and Gynecology (176 citations) and Internal Medicine (58 citations). Sarah Gee has collaborated with scholars based in United Kingdom, Ireland and New Zealand. Frequent co-authors include Steven J. Jackson, Suzanne M. Cotter, D O’Flanagan, Abhishek Das, Deena L. Gibbons, Katie J. Doores, Rachel Marie Tribe, Jeffrey Seow, Emily Pollock and Timothy I. M. Tree. Their work appears in journals such as The Lancet, Eurosurveillance, Journal of Public Health, The Lancet Diabetes & Endocrinology and Leisure Studies.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact